drugset / Trial / NCT00606411

Efficacy and Safety of Topiramate in the Treatment of Sleep-Related Eating Disorder

NCT00606411

Phase 0 Completed 34 enrolled Massachusetts General Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to learn about the safety and effectiveness of oral (taken by mouth) topiramate in treating Sleep-Related Eating Disorder (SRED).

Timeline

Start
2008-01
Primary completion
2018-11-29
Completion
2018-11-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Topiramate Small molecule Oral

Indications